APC anti-mouse CD25 Antibody

Pricing & Availability
Clone
PC61 (See other available formats)
Regulatory Status
RUO
Other Names
IL-2Rα, Ly-43, p55, Tac
Isotype
Rat IgG1, λ
Ave. Rating
Submit a Review
Product Citations
publications
pc61
Con A-stimulated (3 days)splenocytes stained with PC61 APC
  • pc61
    Con A-stimulated (3 days)splenocytes stained with PC61 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
102011 25 µg £37
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102012 100 µg £107
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD25 is a 55 kD glycoprotein also known as the low affinity IL-2Rα, Ly-43, p55, or Tac. It is expressed on activated T and B cells, thymocyte subsets, pre-B cells, and T regulatory cells. In association with CD122 (IL-2Rβ) and CD132 (common γ chain), CD25 forms the high affinity signaling IL-2 receptor.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-2-dependent cytolytic mouse T-cell clone B6.1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD25 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, in vitro blocking of IL-2 binding to low- and high-affinity receptors1-4, growth inhibition of IL-2-dependent T-cell lines1-4, in vivo depletion of CD25+CD4+ Treg cells5-8,10, and immunohistochemical staining of acetone-fixed frozen sections2. PC61 antibody recognizes a different epitope than 3C7 antibody (Cat. No. 101902). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 102040) with endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered. 

Application References

(PubMed link indicates BioLegend citation)
  1. Lowenthal JW, et al. 1985. Nature 315:669. (IP, Block)
  2. Ceredig R, et al. 1985. Nature 314:98. (IP, IHC, Block)
  3. Lowenthal JW, et al. 1985. J. Immunol. 135:3988. (Block)
  4. Moreau JL, et al. 1987. Eur. J. Immunol. 17:929. (Block)
  5. Takahashi T, et al. 2000. J. Exp. Med. 192:303. (Deplete)
  6. Onizuka S, et al. 1999. Cancer Res. 59:3128. (Deplete)
  7. Lei TC, et al. 2005. Blood 105:4865. (Deplete)
  8. Pasare C, et al. 2004. Immunity 21:733. (Deplete)
  9. León-Ponte M, et al. 2007. Blood 109:3139.
  10. Cao OW, et al. 2007. Blood doi:10.1182/blood-2007-02-073304. (Deplete)
  11. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719.
  12. Liu F, et al. 2011. Arch Toxicol. 85:1383. PubMed
  13. Anguela XM, et al. 2013. Diabetes. 62:551. PubMed
Product Citations
  1. Schuster M, et al. 2017. J Immunol. 199:920. PubMed
  2. Tian J, et al. 2021. Autophagy. 17:2586. PubMed
  3. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  4. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  5. Prajeeth C,et al. 2017. J Neuroinflammation.. 10.1186/s12974-017-0978-3. PubMed
  6. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  7. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
  8. Kolbus D, et al. 2011. Immunobiology. 216:663. PubMed
  9. Noris M, et al. 2009. J Immunol. 183:4249. PubMed
  10. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  11. Waysbort N, et al. 2013. J Immunol. 191:5822. PubMed
  12. Gravano D, et al. 2010. PLoS One. 5:e13528. PubMed
  13. Annu K, et al. 2020. Sci Rep. 10:2359. PubMed
  14. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  15. Shi L, et al. 2021. Immunity. . PubMed
  16. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  17. Kang TH, et al. 2019. Tissue Eng Regen Med. 16:539. PubMed
  18. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  19. Stahlhut M, et al. 2021. Sci Rep. 11:5294. PubMed
  20. Horikoshi M, et al. 2012. PLoS One. 7:e51215. PubMed
  21. Min H, et al. 2015. PLoS One. 10: 0138201. PubMed
  22. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  23. Zimmermann J, et al. 2017. Eur J Immunol. 10.1002/eji.201747100. PubMed
  24. Rengarajan S, et al. 2020. Cell Rep Med. :1. PubMed
  25. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  26. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  27. Park D, et al. 2020. Cancer Res. 80:4172. PubMed
  28. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  29. Wang SS, et al. 2021. Biomedicines. 9:. PubMed
  30. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  31. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  32. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  33. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  34. Glassman CR, et al. 2021. eLife. 10:00. PubMed
  35. Dou G, et al. 2020. Sci Adv. 6:eaba2987. PubMed
  36. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  37. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  38. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  39. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  40. Wigren M, et al. 2011. J Intern Med. 269:546. PubMed
  41. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  42. Pierini A, et al. 2017. JCI Insight. 2. PubMed
  43. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  44. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  45. Webb ER, et al. 2022. iScience. 25:104995. PubMed
  46. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  47. Oomizu S, et al. 2012. Clin Immunol. 143:51. PubMed
  48. Liu X, et al. 2021. Int J Nanomedicine. 16:5675. PubMed
  49. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  50. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  51. Kolev M, et al. 2020. Immunity. 52(3):513-527. PubMed
  52. Aftabizadeh M, et al. 2021. JCI Insight. 6:. PubMed
  53. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  54. Kang CK, et al. 2021. J Infect Dis. 224:39. PubMed
  55. Tu J, et al. 2022. Mol Ther Nucleic Acids. 27:733. PubMed
  56. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  57. Long C, et al. 2016. Toxicol Sci. 152: 85 - 98. PubMed
  58. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  59. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  60. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  61. Ahn SH, et al. 2022. Front Endocrinol (Lausanne). 13:846226. PubMed
  62. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  63. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  64. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  65. Barbet G, et al. 2018. Immunity. 48:584. PubMed
  66. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  67. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  68. O'Donoghue GP, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  69. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  70. Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed
  71. Tanaka S, et al. 2016. Appl Envir Microbiol. 82: 2693 - 2699. PubMed
  72. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  73. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  74. Schuster M, et al. 2019. Front Immunol. 10:1583. PubMed
  75. Alenazy MF, et al. 2022. PLoS One. 17:e0271689. PubMed
  76. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  77. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  78. Tassi I, et al. 2014. J Immunol. 193:4303. PubMed
  79. Wong E, et al. 2015. J Immunol. 194:4130. PubMed
  80. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  81. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  82. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  83. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  84. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  85. Kashiwakura Y, et al. 2020. Clinical & Experimental Immunology. 202(1):119-135. PubMed
  86. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  87. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  88. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  89. Angelou CC, et al. 2020. Frontiers in Immunology. 2.586805556. PubMed
  90. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  91. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  92. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  93. Park JS, et al. 2022. J Transl Med. 20:85. PubMed
  94. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_312860 (BioLegend Cat. No. 102011)
AB_312861 (BioLegend Cat. No. 102012)

Antigen Details

Structure
Forms high affinity IL-2R with IL-2Rβ (CD122) and IL-2Rγ (CD132), 55 kD
Distribution

Activated T cells and B cells, thymocyte subset, pre-B cells, T regulatory cells

Function
IL-2 receptor
Ligand/Receptor
IL-2
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References
  1. Taniguchi T, et al. 1993. Cell 73:5-8.
  2. Waldmann TA. 1991. J Biol Chem. 266:2681-4.
  3. Read S, et al. 2000. J Exp Med. 192:295-302.
  4. Lowenthal JW, et al. 1985. J Immunol. 135:3988-94.
Gene ID
16184 View all products for this Gene ID
UniProt
View information about CD25 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD25

  • Biotin anti-mouse CD25

  • FITC anti-mouse CD25

  • PE anti-mouse CD25

  • PE/Cyanine5 anti-mouse CD25

  • Purified anti-mouse CD25

  • PE/Cyanine7 anti-mouse CD25

  • Alexa Fluor® 488 anti-mouse CD25

  • Alexa Fluor® 647 anti-mouse CD25

  • Pacific Blue™ anti-mouse CD25

  • Alexa Fluor® 700 anti-mouse CD25

  • APC/Cyanine7 anti-mouse CD25

  • PerCP/Cyanine5.5 anti-mouse CD25

  • PerCP anti-mouse CD25

  • Brilliant Violet 421™ anti-mouse CD25

  • Brilliant Violet 605™ anti-mouse CD25

  • Brilliant Violet 650™ anti-mouse CD25

  • Ultra-LEAF™ Purified anti-mouse CD25

  • Brilliant Violet 510™ anti-mouse CD25

  • PE/Dazzle™ 594 anti-mouse CD25

  • Brilliant Violet 711™ anti-mouse CD25

  • Brilliant Violet 785™ anti-mouse CD25

  • Alexa Fluor® 594 anti-mouse CD25

  • APC/Fire™ 750 anti-mouse CD25

  • TotalSeq™-A0097 anti-mouse CD25

  • KIRAVIA Blue 520™ anti-mouse CD25

  • TotalSeq™-B0097 anti-mouse CD25

  • TotalSeq™-C0097 anti-mouse CD25

  • Spark NIR™ 685 anti-mouse CD25 Antibody

  • PE/Fire™ 640 anti-mouse CD25

  • Spark YG™ 581 anti-mouse CD25

  • APC/Fire™ 810 anti-mouse CD25

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account